Drug Pipeline

ACP-204 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
3
Phase 3
1
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-30 NCT07095465
Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis		 Trial sites expanded: 12 -> 15 locations
Active Studies by Phase
Phase 3
2
Phase 2/3
1
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07095465 Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis Lewy Body Dementia Psychosis Enrolling by Invitation
NCT06194799 ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study Alzheimer's Disease Psychosis Enrolling by Invitation
Phase 2/3
NCT06159673 ACP-204 in Adults With Alzheimer's Disease Psychosis Alzheimer's Disease Psychosis Recruiting
Phase 2
NCT07029581 Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis Lewy Body Dementia Psychosis Recruiting
Sponsors Running ACP-204 Trials
ACADIA Pharmaceuticals Inc. (4)
Disease Areas
Alzheimer's Disease (2) Dementia (2)
Get alerts when ACP-204 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free